세계의 분자 클로스트리듐 디피실리 진단 장비 시장예측 2021년-2026년

■ 영문 제목 : Global Molecular Clostridium Difficile Diagnostic Equipment Market Growth 2021-2026

LP Information가 발행한 조사보고서이며, 코드는 LPI-2201K02364 입니다.■ 상품코드 : LPI-2201K02364
■ 조사/발행회사 : LP Information
■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.)
■ 페이지수 : 107
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의료장치
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1명 열람용)USD3,660 ⇒환산₩4,941,000견적의뢰/주문/질문
Multi User (5명 열람용)USD5,490 ⇒환산₩7,411,500견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)USD7,320 ⇒환산₩9,882,000견적의뢰/구입/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
본 조사보고서는 분자 클로스트리듐 디피실리 진단 장비의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (휴대형, 데스크탑형)와 용도별 시장규모 (병원 및 진료소, 진단 연구소, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 분자 클로스트리듐 디피실리 진단 장비 시장 점유율
- 지역별 분자 클로스트리듐 디피실리 진단 장비 시장규모
- 주요지역의 종류별 시장규모 (휴대형, 데스크탑형)
- 주요지역의 용도별 시장규모 (병원 및 진료소, 진단 연구소, 기타)
- 미주의 분자 클로스트리듐 디피실리 진단 장비 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 분자 클로스트리듐 디피실리 진단 장비 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 분자 클로스트리듐 디피실리 진단 장비 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 분자 클로스트리듐 디피실리 진단 장비 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 분자 클로스트리듐 디피실리 진단 장비 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Roche, Thermo Fisher Scientific, Merck, Pfizer, Actelion Pharmaceuticals, Abbott Laboratories, Trinity Biotech, Summit Therapeutics, Baxter International, Sanofi, Novartis, AstraZeneca
- 조사의 결과/결론
■ 보고서 개요

According to this latest study, the 2021 growth of Molecular Clostridium Difficile Diagnostic Equipment will have significant change from previous year. By the most conservative estimates of global Molecular Clostridium Difficile Diagnostic Equipment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Molecular Clostridium Difficile Diagnostic Equipment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Clostridium Difficile Diagnostic Equipment market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Portable
Desktop

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals & Clinics
Diagnostic Laboratories
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Roche
Thermo Fisher Scientific
Merck
Pfizer
Actelion Pharmaceuticals
Abbott Laboratories
Trinity Biotech
Summit Therapeutics
Baxter International
Sanofi
Novartis
AstraZeneca

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molecular Clostridium Difficile Diagnostic Equipment Consumption 2016-2026
2.1.2 Molecular Clostridium Difficile Diagnostic Equipment Consumption CAGR by Region
2.2 Molecular Clostridium Difficile Diagnostic Equipment Segment by Type
2.2.1 Portable
2.2.2 Desktop
2.3 Molecular Clostridium Difficile Diagnostic Equipment Sales by Type
2.3.1 Global Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Type (2016-2021)
2.3.2 Global Molecular Clostridium Difficile Diagnostic Equipment Revenue and Market Share by Type (2016-2021)
2.3.3 Global Molecular Clostridium Difficile Diagnostic Equipment Sale Price by Type (2016-2021)
2.4 Molecular Clostridium Difficile Diagnostic Equipment Segment by Application
2.4.1 Hospitals & Clinics
2.4.2 Diagnostic Laboratories
2.4.3 Others
2.5 Molecular Clostridium Difficile Diagnostic Equipment Sales by Application
2.5.1 Global Molecular Clostridium Difficile Diagnostic Equipment Sale Market Share by Application (2016-2021)
2.5.2 Global Molecular Clostridium Difficile Diagnostic Equipment Revenue and Market Share by Application (2016-2021)
2.5.3 Global Molecular Clostridium Difficile Diagnostic Equipment Sale Price by Application (2016-2021)

3 Global Molecular Clostridium Difficile Diagnostic Equipment by Company
3.1 Global Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Company
3.1.1 Global Molecular Clostridium Difficile Diagnostic Equipment Sales by Company (2019-2021)
3.1.2 Global Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Company (2019-2021)
3.2 Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Company
3.2.1 Global Molecular Clostridium Difficile Diagnostic Equipment Revenue by Company (2019-2021)
3.2.2 Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Company (2019-2021)
3.3 Global Molecular Clostridium Difficile Diagnostic Equipment Sale Price by Company
3.4 Global Manufacturers Molecular Clostridium Difficile Diagnostic Equipment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Molecular Clostridium Difficile Diagnostic Equipment Product Location Distribution
3.4.2 Players Molecular Clostridium Difficile Diagnostic Equipment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Molecular Clostridium Difficile Diagnostic Equipment by Region
4.1 Global Molecular Clostridium Difficile Diagnostic Equipment by Region
4.1.1 Global Molecular Clostridium Difficile Diagnostic Equipment Sales by Region
4.1.2 Global Molecular Clostridium Difficile Diagnostic Equipment Revenue by Region
4.2 Americas Molecular Clostridium Difficile Diagnostic Equipment Sales Growth
4.3 APAC Molecular Clostridium Difficile Diagnostic Equipment Sales Growth
4.4 Europe Molecular Clostridium Difficile Diagnostic Equipment Sales Growth
4.5 Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Sales Growth

5 Americas
5.1 Americas Molecular Clostridium Difficile Diagnostic Equipment Sales by Country
5.1.1 Americas Molecular Clostridium Difficile Diagnostic Equipment Sales by Country (2016-2021)
5.1.2 Americas Molecular Clostridium Difficile Diagnostic Equipment Revenue by Country (2016-2021)
5.2 Americas Molecular Clostridium Difficile Diagnostic Equipment Sales by Type
5.3 Americas Molecular Clostridium Difficile Diagnostic Equipment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Molecular Clostridium Difficile Diagnostic Equipment Sales by Region
6.1.1 APAC Molecular Clostridium Difficile Diagnostic Equipment Sales by Region (2016-2021)
6.1.2 APAC Molecular Clostridium Difficile Diagnostic Equipment Revenue by Region (2016-2021)
6.2 APAC Molecular Clostridium Difficile Diagnostic Equipment Sales by Type
6.3 APAC Molecular Clostridium Difficile Diagnostic Equipment Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Molecular Clostridium Difficile Diagnostic Equipment by Country
7.1.1 Europe Molecular Clostridium Difficile Diagnostic Equipment Sales by Country (2016-2021)
7.1.2 Europe Molecular Clostridium Difficile Diagnostic Equipment Revenue by Country (2016-2021)
7.2 Europe Molecular Clostridium Difficile Diagnostic Equipment Sales by Type
7.3 Europe Molecular Clostridium Difficile Diagnostic Equipment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment by Country
8.1.1 Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Sales by Country (2016-2021)
8.1.2 Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Revenue by Country (2016-2021)
8.2 Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Sales by Type
8.3 Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Molecular Clostridium Difficile Diagnostic Equipment Distributors
10.3 Molecular Clostridium Difficile Diagnostic Equipment Customer

11 Global Molecular Clostridium Difficile Diagnostic Equipment Market Forecast
11.1 Global Molecular Clostridium Difficile Diagnostic Equipment Forecast by Region
11.1.1 Global Molecular Clostridium Difficile Diagnostic Equipment Forecast by Regions (2021-2026)
11.2.2 Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Molecular Clostridium Difficile Diagnostic Equipment Forecast by Type
11.7 Global Molecular Clostridium Difficile Diagnostic Equipment Forecast by Application

12 Key Players Analysis
12.1 Roche
12.1.1 Roche Company Information
12.1.2 Roche Molecular Clostridium Difficile Diagnostic Equipment Product Offered
12.1.3 Roche Molecular Clostridium Difficile Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Roche Main Business Overview
12.1.5 Roche Latest Developments
12.2 Thermo Fisher Scientific
12.2.1 Thermo Fisher Scientific Company Information
12.2.2 Thermo Fisher Scientific Molecular Clostridium Difficile Diagnostic Equipment Product Offered
12.2.3 Thermo Fisher Scientific Molecular Clostridium Difficile Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Thermo Fisher Scientific Main Business Overview
12.2.5 Thermo Fisher Scientific Latest Developments
12.3 Merck
12.3.1 Merck Company Information
12.3.2 Merck Molecular Clostridium Difficile Diagnostic Equipment Product Offered
12.3.3 Merck Molecular Clostridium Difficile Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Merck Main Business Overview
12.3.5 Merck Latest Developments
12.4 Pfizer
12.4.1 Pfizer Company Information
12.4.2 Pfizer Molecular Clostridium Difficile Diagnostic Equipment Product Offered
12.4.3 Pfizer Molecular Clostridium Difficile Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Pfizer Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Actelion Pharmaceuticals
12.5.1 Actelion Pharmaceuticals Company Information
12.5.2 Actelion Pharmaceuticals Molecular Clostridium Difficile Diagnostic Equipment Product Offered
12.5.3 Actelion Pharmaceuticals Molecular Clostridium Difficile Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Actelion Pharmaceuticals Main Business Overview
12.5.5 Actelion Pharmaceuticals Latest Developments
12.6 Abbott Laboratories
12.6.1 Abbott Laboratories Company Information
12.6.2 Abbott Laboratories Molecular Clostridium Difficile Diagnostic Equipment Product Offered
12.6.3 Abbott Laboratories Molecular Clostridium Difficile Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Abbott Laboratories Main Business Overview
12.6.5 Abbott Laboratories Latest Developments
12.7 Trinity Biotech
12.7.1 Trinity Biotech Company Information
12.7.2 Trinity Biotech Molecular Clostridium Difficile Diagnostic Equipment Product Offered
12.7.3 Trinity Biotech Molecular Clostridium Difficile Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Trinity Biotech Main Business Overview
12.7.5 Trinity Biotech Latest Developments
12.8 Summit Therapeutics
12.8.1 Summit Therapeutics Company Information
12.8.2 Summit Therapeutics Molecular Clostridium Difficile Diagnostic Equipment Product Offered
12.8.3 Summit Therapeutics Molecular Clostridium Difficile Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Summit Therapeutics Main Business Overview
12.8.5 Summit Therapeutics Latest Developments
12.9 Baxter International
12.9.1 Baxter International Company Information
12.9.2 Baxter International Molecular Clostridium Difficile Diagnostic Equipment Product Offered
12.9.3 Baxter International Molecular Clostridium Difficile Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Baxter International Main Business Overview
12.9.5 Baxter International Latest Developments
12.10 Sanofi
12.10.1 Sanofi Company Information
12.10.2 Sanofi Molecular Clostridium Difficile Diagnostic Equipment Product Offered
12.10.3 Sanofi Molecular Clostridium Difficile Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Sanofi Main Business Overview
12.10.5 Sanofi Latest Developments
12.11 Novartis
12.11.1 Novartis Company Information
12.11.2 Novartis Molecular Clostridium Difficile Diagnostic Equipment Product Offered
12.11.3 Novartis Molecular Clostridium Difficile Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Novartis Main Business Overview
12.11.5 Novartis Latest Developments
12.12 AstraZeneca
12.12.1 AstraZeneca Company Information
12.12.2 AstraZeneca Molecular Clostridium Difficile Diagnostic Equipment Product Offered
12.12.3 AstraZeneca Molecular Clostridium Difficile Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 AstraZeneca Main Business Overview
12.12.5 AstraZeneca Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Molecular Clostridium Difficile Diagnostic Equipment Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Portable
Table 3. Major Players of Desktop
Table 4. Global Molecular Clostridium Difficile Diagnostic Equipment Sales by Type (2016-2021) & (K Units)
Table 5. Global Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Type (2016-2021)
Table 6. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue by Type (2016-2021) & ($ million)
Table 7. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Type (2016-2021)
Table 8. Global Molecular Clostridium Difficile Diagnostic Equipment Sale Price by Type (2016-2021)
Table 9. Global Molecular Clostridium Difficile Diagnostic Equipment Sales by Application (2016-2021) & (K Units)
Table 10. Global Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Application (2016-2021)
Table 11. Global Molecular Clostridium Difficile Diagnostic Equipment Value by Application (2016-2021)
Table 12. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Application (2016-2021)
Table 13. Global Molecular Clostridium Difficile Diagnostic Equipment Sale Price by Application (2016-2021)
Table 14. Global Molecular Clostridium Difficile Diagnostic Equipment Sales by Company (2019-2021) & (K Units)
Table 15. Global Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Company (2019-2021)
Table 16. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Company (2019-2021)
Table 18. Global Molecular Clostridium Difficile Diagnostic Equipment Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Molecular Clostridium Difficile Diagnostic Equipment Producing Area Distribution and Sales Area
Table 20. Players Molecular Clostridium Difficile Diagnostic Equipment Products Offered
Table 21. Molecular Clostridium Difficile Diagnostic Equipment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Molecular Clostridium Difficile Diagnostic Equipment Sales by Region (2016-2021) (K Units)
Table 25. Global Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Region (2016-2021)
Table 26. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Region (2016-2021)
Table 28. Americas Molecular Clostridium Difficile Diagnostic Equipment Sales by Country (2016-2021) & (K Units)
Table 29. Americas Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Country (2016-2021)
Table 30. Americas Molecular Clostridium Difficile Diagnostic Equipment Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Country (2016-2021)
Table 32. Americas Molecular Clostridium Difficile Diagnostic Equipment Sales by Type (2016-2021) & (K Units)
Table 33. Americas Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Type (2016-2021)
Table 34. Americas Molecular Clostridium Difficile Diagnostic Equipment Sales by Application (2016-2021) & (K Units)
Table 35. Americas Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Application (2016-2021)
Table 36. APAC Molecular Clostridium Difficile Diagnostic Equipment Sales by Region (2016-2021) & (K Units)
Table 37. APAC Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Region (2016-2021)
Table 38. APAC Molecular Clostridium Difficile Diagnostic Equipment Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Region (2016-2021)
Table 40. APAC Molecular Clostridium Difficile Diagnostic Equipment Sales by Type (2016-2021) & (K Units)
Table 41. APAC Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Type (2016-2021)
Table 42. APAC Molecular Clostridium Difficile Diagnostic Equipment Sales by Application (2016-2021) & (K Units)
Table 43. APAC Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Application (2016-2021)
Table 44. Europe Molecular Clostridium Difficile Diagnostic Equipment Sales by Country (2016-2021) & (K Units)
Table 45. Europe Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Country (2016-2021)
Table 46. Europe Molecular Clostridium Difficile Diagnostic Equipment Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Country (2016-2021)
Table 48. Europe Molecular Clostridium Difficile Diagnostic Equipment Sales by Type (2016-2021) & (K Units)
Table 49. Europe Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Type (2016-2021)
Table 50. Europe Molecular Clostridium Difficile Diagnostic Equipment Sales by Application (2016-2021) & (K Units)
Table 51. Europe Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Molecular Clostridium Difficile Diagnostic Equipment
Table 61. Key Application and Potential Industries of Molecular Clostridium Difficile Diagnostic Equipment
Table 62. Key Challenges of Molecular Clostridium Difficile Diagnostic Equipment
Table 63. Key Trends of Molecular Clostridium Difficile Diagnostic Equipment
Table 64. Molecular Clostridium Difficile Diagnostic Equipment Distributors List
Table 65. Molecular Clostridium Difficile Diagnostic Equipment Customer List
Table 66. Global Molecular Clostridium Difficile Diagnostic Equipment Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Molecular Clostridium Difficile Diagnostic Equipment Consumption Market Forecast by Region
Table 68. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Molecular Clostridium Difficile Diagnostic Equipment Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Molecular Clostridium Difficile Diagnostic Equipment Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Molecular Clostridium Difficile Diagnostic Equipment Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Molecular Clostridium Difficile Diagnostic Equipment Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Molecular Clostridium Difficile Diagnostic Equipment Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Molecular Clostridium Difficile Diagnostic Equipment Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Molecular Clostridium Difficile Diagnostic Equipment Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Molecular Clostridium Difficile Diagnostic Equipment Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share Forecast by Application (2021-2026)
Table 86. Roche Basic Information, Molecular Clostridium Difficile Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 87. Roche Molecular Clostridium Difficile Diagnostic Equipment Product Offered
Table 88. Roche Molecular Clostridium Difficile Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 89. Roche Main Business
Table 90. Roche Latest Developments
Table 91. Thermo Fisher Scientific Basic Information, Molecular Clostridium Difficile Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 92. Thermo Fisher Scientific Molecular Clostridium Difficile Diagnostic Equipment Product Offered
Table 93. Thermo Fisher Scientific Molecular Clostridium Difficile Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 94. Thermo Fisher Scientific Main Business
Table 95. Thermo Fisher Scientific Latest Developments
Table 96. Merck Basic Information, Molecular Clostridium Difficile Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 97. Merck Molecular Clostridium Difficile Diagnostic Equipment Product Offered
Table 98. Merck Molecular Clostridium Difficile Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 99. Merck Main Business
Table 100. Merck Latest Developments
Table 101. Pfizer Basic Information, Molecular Clostridium Difficile Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 102. Pfizer Molecular Clostridium Difficile Diagnostic Equipment Product Offered
Table 103. Pfizer Molecular Clostridium Difficile Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 104. Pfizer Main Business
Table 105. Pfizer Latest Developments
Table 106. Actelion Pharmaceuticals Basic Information, Molecular Clostridium Difficile Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 107. Actelion Pharmaceuticals Molecular Clostridium Difficile Diagnostic Equipment Product Offered
Table 108. Actelion Pharmaceuticals Molecular Clostridium Difficile Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 109. Actelion Pharmaceuticals Main Business
Table 110. Actelion Pharmaceuticals Latest Developments
Table 111. Abbott Laboratories Basic Information, Molecular Clostridium Difficile Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 112. Abbott Laboratories Molecular Clostridium Difficile Diagnostic Equipment Product Offered
Table 113. Abbott Laboratories Molecular Clostridium Difficile Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 114. Abbott Laboratories Main Business
Table 115. Abbott Laboratories Latest Developments
Table 116. Trinity Biotech Basic Information, Molecular Clostridium Difficile Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 117. Trinity Biotech Molecular Clostridium Difficile Diagnostic Equipment Product Offered
Table 118. Trinity Biotech Molecular Clostridium Difficile Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 119. Trinity Biotech Main Business
Table 120. Trinity Biotech Latest Developments
Table 121. Summit Therapeutics Basic Information, Molecular Clostridium Difficile Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 122. Summit Therapeutics Molecular Clostridium Difficile Diagnostic Equipment Product Offered
Table 123. Summit Therapeutics Molecular Clostridium Difficile Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 124. Summit Therapeutics Main Business
Table 125. Summit Therapeutics Latest Developments
Table 126. Baxter International Basic Information, Molecular Clostridium Difficile Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 127. Baxter International Molecular Clostridium Difficile Diagnostic Equipment Product Offered
Table 128. Baxter International Molecular Clostridium Difficile Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 129. Baxter International Main Business
Table 130. Baxter International Latest Developments
Table 131. Sanofi Basic Information, Molecular Clostridium Difficile Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 132. Sanofi Molecular Clostridium Difficile Diagnostic Equipment Product Offered
Table 133. Sanofi Molecular Clostridium Difficile Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 134. Sanofi Main Business
Table 135. Sanofi Latest Developments
Table 136. Novartis Basic Information, Molecular Clostridium Difficile Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 137. Novartis Molecular Clostridium Difficile Diagnostic Equipment Product Offered
Table 138. Novartis Molecular Clostridium Difficile Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 139. Novartis Main Business
Table 140. Novartis Latest Developments
Table 141. AstraZeneca Basic Information, Molecular Clostridium Difficile Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 142. AstraZeneca Molecular Clostridium Difficile Diagnostic Equipment Product Offered
Table 143. AstraZeneca Molecular Clostridium Difficile Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 144. AstraZeneca Main Business
Table 145. AstraZeneca Latest Developments
List of Figures
Figure 1. Picture of Molecular Clostridium Difficile Diagnostic Equipment
Figure 2. Molecular Clostridium Difficile Diagnostic Equipment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Molecular Clostridium Difficile Diagnostic Equipment Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Molecular Clostridium Difficile Diagnostic Equipment Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Portable
Figure 10. Product Picture of Desktop
Figure 11. Global Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Type in 2020
Figure 12. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Type (2016-2021)
Figure 13. Molecular Clostridium Difficile Diagnostic Equipment Consumed in Hospitals & Clinics
Figure 14. Global Molecular Clostridium Difficile Diagnostic Equipment Market: Hospitals & Clinics (2016-2021) & (K Units)
Figure 15. Molecular Clostridium Difficile Diagnostic Equipment Consumed in Diagnostic Laboratories
Figure 16. Global Molecular Clostridium Difficile Diagnostic Equipment Market: Diagnostic Laboratories (2016-2021) & (K Units)
Figure 17. Molecular Clostridium Difficile Diagnostic Equipment Consumed in Others
Figure 18. Global Molecular Clostridium Difficile Diagnostic Equipment Market: Others (2016-2021) & (K Units)
Figure 19. Global Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Application (2016-2021)
Figure 20. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Application in 2020
Figure 21. Molecular Clostridium Difficile Diagnostic Equipment Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Company in 2020
Figure 23. Global Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Regions (2016-2021)
Figure 24. Global Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Region in 2020
Figure 25. Americas Molecular Clostridium Difficile Diagnostic Equipment Sales 2016-2021 (K Units)
Figure 26. Americas Molecular Clostridium Difficile Diagnostic Equipment Revenue 2016-2021 ($ Millions)
Figure 27. APAC Molecular Clostridium Difficile Diagnostic Equipment Sales 2016-2021 (K Units)
Figure 28. APAC Molecular Clostridium Difficile Diagnostic Equipment Revenue 2016-2021 ($ Millions)
Figure 29. Europe Molecular Clostridium Difficile Diagnostic Equipment Sales 2016-2021 (K Units)
Figure 30. Europe Molecular Clostridium Difficile Diagnostic Equipment Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Revenue 2016-2021 ($ Millions)
Figure 33. Americas Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Country in 2020
Figure 34. Americas Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Country in 2020
Figure 35. Americas Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Type in 2020
Figure 36. Americas Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Application in 2020
Figure 37. United States Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Region in 2020
Figure 42. APAC Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Regions in 2020
Figure 43. APAC Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Type in 2020
Figure 44. APAC Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Application in 2020
Figure 45. China Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Country in 2020
Figure 52. Europe Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Country in 2020
Figure 53. Europe Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Type in 2020
Figure 54. Europe Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Application in 2020
Figure 55. Germany Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Molecular Clostridium Difficile Diagnostic Equipment Sales Market Share by Application in 2020
Figure 64. Egypt Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Molecular Clostridium Difficile Diagnostic Equipment Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
※본 조사보고서 [세계의 분자 클로스트리듐 디피실리 진단 장비 시장예측 2021년-2026년] (코드 : LPI-2201K02364) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 분자 클로스트리듐 디피실리 진단 장비 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!